Compound Ventures invests in Halcyon Health - Dentons ventureBeyond

Funding Rounds

▤ Summary

Compound Ventures invested in Halcyon Health through the company’s Series Seed Preferred Stock round. Dentons Venture Technology and Emerging Growth practice advised Compound Ventures on the transaction. Halcyon Health operates in the healthcare software space, making the deal relevant to the ISV audience. The item focuses on the financing event rather than the product or operations of the company.

$ Funding

$
Amount None Total raised
□
Date February 4, 2020 Announcement date
◎
Investors Dentons Lead investors
▥
Company - Funded company

▥ Classifications

industries
No industries detected
applications
No applications detected

◇ AskAI Classifications

Labels
No AI classifications detected

▦ Linked Companies